IC
HRMY icon

IEQ Capital’s Harmony Biosciences HRMY Stock Holding History

IEQ Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
53,762
+15,864
+42% +$500K 0.01% 814
2026
Q1 		$1.06M Sell
37,898
-46,242
-55% -$1.52M ﹤0.01% 1025
2025
Q4 		$3.15M Buy
84,140
+57,582
+217% +$1.89M 0.01% 658
2025
Q3 		$732K Buy
26,558
+17,138
+182% +$590K ﹤0.01% 1133
2025
Q2 		$298K Buy
9,420
+3,337
+55% +$107K ﹤0.01% 1403
2025
Q1 		$202K Buy
+6,083
New +$218K ﹤0.01% 1381

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's HRMY Position: Q2 2026 in Review

IEQ Capital increased its Harmony Biosciences (HRMY) stake by 42% in Q2 2026, buying an estimated $500K and bringing the position to 53,762 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #814.

IEQ Capital first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.15M in Q4 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • IEQ Capital held 53,762 shares of Harmony Biosciences worth $1.96M as of Q2 2026.
  • IEQ Capital bought 15,864 Harmony Biosciences shares in Q2 2026, an estimated $500K.
  • Harmony Biosciences made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #814 holding.
  • IEQ Capital first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Harmony Biosciences position peaked at $3.15M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.